Question Bank › Locus of control flip

Locus of control flip

Locus of control flip: management says the outcome is in its own hands, and names what it controls

Calls Tested
215
Answered YES
49
Hit Rate
22.8%
rare by design

First Financial Bancorp. (FFBC) — this company's answers

NO on the Q1 2016 call 2016-04-22 B
The model's full reasoning — Q1 2016 call → NO我们根据提供的电话会议记录来判断。管理层是否传达了未来结果主要由公司自身控制的因素决定,并指出了至少一个具体的、可控制的、已经存在的驱动因素。 分析: - 管理层多次提到有机增长、执行战略、费用管理、贷款增长等。 - 例如,Claude Davis说“我们专注于服务客户,保持纪律”,提到“有机增长”和“战略目标”。 - Tony Stollings提到“贷款增长强劲”,“管道强劲”,但这些都是当前状况。 - John Gavigan提到“费用管理”,“预期运营费用率”。 - 关于未来,管理层说“我们预计净息差相对稳定”,但未明确说结果由自身控制。 - 关键点:管理层是否明确表示未来结果由自身执行决定,而非外部条件?在回答关于M&A时,Claude说“我们最关注有机增长和执行核心战略”,这有点自我决定的意思。 - 但有没有具体的、已存在的驱动因素?例如,他们提到“两个全国性平台,First Franchise和Oak Street”,这些是已有的资产。他们提到“贷款管道强劲”,但管道是未来的,不是已实现的。 - 他们提到“费用收入改进计划”,但说“这些是长期策略,不是第二季度事件”,所以不是已经产生效果的。 - 他们提到“分支整合”已经完成,但那是过去的事。 - 他们提到“利率敏感度”,但那是外部因素。 关键:管理层是否明确说“结果由我们控制”?在回答关于增长时,他们说“我们继续看到机会”,但未明确说“不依赖市场”。在回答关于M&A时,他们说“我们最关注有机增长”,但未说“我们不需要市场帮助”。 另外,他们提到“我们仍然看到信贷需求”,这暗示外部需求。 我认为管理层没有明确表达“所有权立场”,即未来结果主要由自身控制。他们更多是描述当前状况和计划,但未明确说“结果在我们手中”。他们提到“我们继续看到机会”,但未说“我们决定结果”。 关于具体驱动因素,他们提到“Oak Street”和“First Franchise”是已有的平台,但未说这些将推动改进。他们提到“贷款增长”是当前结果,但未说未来增长由这些驱动。 因此,答案应为NO。

← Back to the full FFBC analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the company's results over the coming periods will be determined mainly by THINGS THE COMPANY ITSELF CONTROLS — its own execution, its own already-identified actions, its own assets or capabilities — rather than by market conditions, industry demand, macroeconomics, prices, or other outside forces, AND does management back that stance by pointing to at least one SPECIFIC, NAMEABLE driver it controls that is already real today? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent posture with both halves present: (1) AN OWNERSHIP STANCE TOWARD THE FUTURE. Management frames the path ahead as substantially self-determined — for example, saying in substance that the outcome is in the company's own hands, that its growth or improvement does not require the market's help or a better environment, that the levers that matter are internal, that whether it delivers comes down to its own execution, or answering questions about external conditions by redirecting to what the company itself is doing. The stance may be stated plainly or emerge clearly from how management consistently explains the road ahead across the call. (2) A NAMED, CONTROLLABLE DRIVER ALREADY IN MOTION. Management identifies at least one concrete thing under its own control that is already real — already underway, in hand, built, signed, launched, staffed, fixed, or being executed now — that it presents as carrying the improvement: for example work already won and being delivered, a capability or capacity already in place being loaded, a product or offering already launched and scaling, an internal fix or change already made whose benefit is arriving, or a self-funded rollout already progressing. The driver may take whatever form fits the industry; what matters is that it belongs to the company, exists today, and is what management points to when explaining why results will improve. Answer NO if management chiefly attributes its future to demand strength, industry tailwinds, pricing environments, seasonality, recovery, or other outside conditions — even optimistically. NO if the self-determination talk is generic confidence ('we control our own destiny', 'execution is our focus') with no specific controllable driver named as already real. NO if the named drivers are plans, pipelines, targets, or hopes not yet in motion. NO if management is mainly blaming external forces for weak results and promising to execute better someday. NO if the environment is described as the main swing factor and the company's own actions as secondary. NO if the posture appears only in an analyst's question or characterization that management does not itself adopt. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ASO Academy Sports and Outdoors, Inc. Q1 2024 2024-06-11 C+
SFIX Stitch Fix, Inc. Q3 2024 2024-06-04 C+
RCEL AVITA Medical, Inc. Q1 2024 2024-05-14 F
LINC Lincoln Educational Services Corporation Q1 2024 2024-05-06 B+
TNET TriNet Group, Inc. Q1 2024 2024-04-26 C
DUOT Duos Technologies Group, Inc. Q4 2023 2024-04-01 F
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
SANG Sangoma Technologies Corporation Q2 2024 2024-02-08 D
GPRO GoPro, Inc. Q4 2023 2024-02-07 F
ALL The Allstate Corporation Q3 2023 2023-11-02 C+
PTLO Portillo's Inc. Q2 2023 2023-08-05 B
SPT Sprout Social, Inc. Q2 2023 2023-08-04 B+
CDE Coeur Mining, Inc. Q1 2023 2023-05-11 C+
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
TSSI TSS, Inc. Q4 2022 2023-04-03 D
DKS DICK'S Sporting Goods, Inc. Q4 2022 2023-03-07 B
ADPT Adaptive Biotechnologies Corporation Q4 2022 2023-02-14 C+
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
ZVIA Zevia PBC Q1 2022 2022-05-12 B
HROW Harrow Health, Inc. Q4 2021 2022-03-10 C
RELY Remitly Global, Inc. Q4 2021 2022-03-02 B
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
ASAN Asana, Inc. Q2 2022 2021-09-01 B+
CLVT Clarivate Plc Q2 2021 2021-07-31 B+
CUBI Customers Bancorp, Inc. Q3 2018 2018-10-26 C+
ASND Ascendis Pharma A/S Q1 2018 2018-05-30 C+
ALLY Ally Financial Inc. Q1 2018 2018-04-26 B+
SCVL Shoe Carnival, Inc. Q4 2017 2018-03-27 C+
UPLD Upland Software, Inc. Q4 2017 2018-03-08 C+
ITCI Intra-Cellular Therapies, Inc. Q4 2017 2018-03-01 D
UNH UnitedHealth Group Incorporated Q4 2017 2018-01-16 A
HSTM HealthStream, Inc. Q3 2017 2017-10-24 C
STKL SunOpta Inc. Q2 2017 2017-08-09 C+
FLEX Flex Ltd. Q1 2018 2017-07-28 F
PTC PTC Inc. Q3 2017 2017-07-19 C+
IONS Ionis Pharmaceuticals, Inc. Q1 2017 2017-05-09 C
BLKB Blackbaud, Inc. Q1 2017 2017-05-02 B+
MRIN Marin Software Incorporated Q4 2016 2017-02-28 D
SXT Sensient Technologies Corporation Q4 2016 2017-02-10 A
ATO Atmos Energy Corporation Q1 2017 2017-02-08 A
EFSC Enterprise Financial Services Corp Q4 2016 2017-01-24 B+
RPM RPM International Inc. Q2 2017 2017-01-05 D
LEE Lee Enterprises, Incorporated Q4 2016 2016-12-09 C
FATE Fate Therapeutics, Inc. Q3 2016 2016-11-07 C
MAT Mattel, Inc. Q3 2016 2016-10-19 C
ARAY Accuray Incorporated Q4 2016 2016-08-17 B
GIS General Mills, Inc. Q4 2016 2016-06-29 B+
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A
SAN Banco Santander, S.A. Q4 2015 2016-01-27 B

How the model reasoned

TNET · Q1 2024 → YESThe question is: Does management convey that the company's results over the coming periods will be determined mainly by THINGS THE COMPANY ITSELF CONTROLS, rather than by market conditions, etc., AND ...YES The transcript shows management framing future results as largely self-determined through internal levers like offsetting attrition with new sales (which they expect to "consistently achieve"), disciplined execution in sales/retention/expenses, and a strategy review to align resources for profitable growth. They back this with specific, already-real drivers: 50 % YoY ACV new sales growth, 28 % YoY growth in tenured sales reps plus productivity gains, and nearly positive sequential core WSE growth in Q1. While acknowledging external headwinds (economic hiring softness, insurance cost inflation), they repeatedly redirect to what they control and point to these internal actions as the primary drivers of improvement. The stance is coherent and not generic. Answer: YES. The question requires "mainly" and "rather than by market conditions, etc."; the transcript meets that threshold by repeatedly emphasizing internal control and execution while treating external factors as secondary headwinds they are managing.
GPRO · Q4 2023 → YESThe question is: Does management convey that the company's results over the coming periods will be determined mainly by THINGS THE COMPANY ITSELF CONTROLS, rather than by market conditions, etc., AND ...YES The transcript shows management framing 2024 results as driven primarily by its own actions: the retail expansion already underway (3,200 doors added, 7,000 targeted), new product launches (four SKUs in 2024), the Forcite acquisition closed this quarter, and the Quik desktop app launched 24 hours ago. They repeatedly tie future growth to these internal levers rather than external demand or macro conditions, while noting external factors only as temporary Q4 headwinds. This meets both criteria. NO if it were mainly external or generic. YES. The stance is coherent and backed by a named, already-real driver (ret 3200 doors + strategy shift). The answer is YES. The question is answered with YES. The final answer is YES. The answer is YES. The answer is YES. The answer is YES. The answer is YES. The answer is YES.
HROW · Q4 2021 → YESThe question is: Does management convey that the company's results over the coming periods will be determined mainly by THINGS THE COMPANY ITSELF CONTROLS, rather than by market conditions, etc., AND ...YES The transcript shows management framing the path ahead as substantially self-determined through its own execution and actions (e.g., "positioning Harrow Health to fulfill its vision," "executing on that vision," "we are expanding our existing commercial infrastructure," "establishing our own internal analytical lab," "we expect to see 2023 number looks like 2024, 2025" via "profits that this team has been able to generate," and "we have that amazing commercial team and we have a large customer base" for launches without dilution). They redirect from external factors like COVID to internal progress and state they will "not dilute our shareholders necessarily to launch AMP-100" due to internal capabilities.

More from the question bank

Betting on one customer's rampProof-point cadenceScarcity premium: the thing the company sellCheck it yourselvesSomeone else already paid for the growthBought-and-paid-for optionalityAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.